• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Turning Point Brands Announces Third Quarter 2025 Results

    11/5/25 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary
    Get the next $TPB alert in real time by email
    • Consolidated Net Sales for Q3 2025 increased 31.2% year-over-year to $119.0 million
    • Modern Oral Net Sales for Q3 2025 increased 627.6% year-over-year to $36.7 million, accounting for 30.8% of total Company Net Sales
    • Q3 2025 Adjusted EBITDA of $31.3 million, up 17.2% over prior year
    • Company increasing 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million)
    • Company increasing full-year Modern Oral sales guidance to $125.0 – 130.0 million (from $100.0 – 110.0 million)

    Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the third quarter ended September 30, 2025.

    Q3 2025 vs. Q3 2024

    • Total consolidated Net Sales increased 31.2% to $119.0 million
      • Stoker's segment Net Sales increased 80.8%
      • Zig-Zag segment Net Sales decreased 10.5%
    • Gross Profit increased 39.7% to $70.4 million
    • Net Income increased 70.3% to $21.1 million
    • Adjusted EBITDA increased 17.2% to $31.3 million (see Schedule A for a reconciliation to net income)
    • Adjusted Net Income increased 18.3% to $19.6 million (see Schedule B for a reconciliation to net income)
    • Diluted EPS of $1.13 and Adjusted Diluted EPS of $1.27 compared to $0.68 and $0.91, respectively, in the same period one year ago (see Schedule B for a reconciliation to Diluted EPS)
    • Company raised $97.5 million of net proceeds at an average price of $98.59 per share under previously announced "At the Market" offering program; capital to be deployed across a variety of high return opportunities to accelerate growth of Modern Oral.

    Graham Purdy, President and CEO, commented, "Our consolidated third quarter results exceeded expectations. Modern Oral sales were $36.7 million, increasing by 22% versus the prior quarter and 628% over the prior year. In addition, we now expect to qualify our first U.S. white pouch production lines in the first half of 2026."

    Stoker's Products Segment (63% of total net sales in the quarter)

    For the third quarter, Stoker's segment net sales increased 80.8% from the prior year to $74.8 million, driven by strong growth in Modern Oral sales, mid-single-digit growth in MST and low-single-digit growth in looseleaf.

    Stoker's segment gross profit increased 95.2% from the prior year and 3.5% sequentially to $45.0 million. Gross margin increased 440 basis points from the prior year to 60.2%.

    Zig-Zag Products Segment (37% of total net sales in the quarter)

    For the third quarter, Zig-Zag segment net sales decreased 10.5% from the prior year and 6.1% sequentially to $44.2 million. Excluding the previously discussed wind-down of our Clipper business, Zig-Zag was up mid-single-digits sequentially, which slightly beat our expectations.

    Zig-Zag segment gross profit decreased 7.1% from the prior year but increased 9.9% sequentially to $25.4 million. Gross margin increased 210 basis points from the prior year to 57.5%.

    Performance Measures in the Third Quarter

    Third quarter 2025 consolidated selling, general and administrative ("SG&A") expenses increased 50.5% from the prior year and 10.5% sequentially to $44.5 million, inclusive of increased Modern Oral-related sales and marketing investments and increased outbound freight costs.

    Third quarter SG&A included the following notable items:

    • $0.5 million of FDA PMTA-related expenses for Modern Oral products compared to $1.2 million in the prior year period; and
    • $0.8 million of transaction-related costs compared to $0.9 million in the prior year period.

    Total gross debt as of September 30, 2025 was $300.0 million. Net debt (total gross debt less unrestricted cash) as of September 30, 2025 was $98.8 million. The Company ended the quarter with total liquidity of $267.8 million, comprised of $201.2 million in cash and $66.6 million of availability under an asset backed revolving credit facility.

    Consistent with the Company's policy of maintaining active buyback and sales authorizations to maximize capital markets flexibility, the Company plans to amend its ATM prospectus supplement and buyback authorization to provide for $200 million of capacity under each program. There are no current plans to transact under the updated authorizations.

    2025 Outlook

    The Company is increasing full-year 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million) and projected full-year 2025 Modern Oral sales to $125.0 – 130.0 million (from $100.0 – 110.0 million).

    Earnings Conference Call

    As previously disclosed, a conference call with the investment community to review TPB's financial results has been scheduled for 8:30 a.m. Eastern on Wednesday, November 5, 2025. Investment community participants should dial in 10 minutes ahead of time using the toll-free number (800) 715-9871 (international participants should call (646) 307-1963) and follow the audio prompts after typing in the event ID: 6640134. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the website two hours following the call.

    Non-GAAP Financial Measures

    In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Adjusted Operating Income (Loss). A reconciliation of these non-GAAP financial measures accompanies this release.

    About Turning Point Brands, Inc.

    Turning Point Brands (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including smoking accessories and consumables with active ingredients through its Zig-Zag®, Stoker's®, FRE®, and Alp Pouch® brands. TPB's products are available in more than 220,000 retail outlets in North America, and on sites such as www.zigzag.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, those included in the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

    This press release contains TPB's preliminary determinations and current expectations, and such information is inherently uncertain. The preliminary estimates provided herein have been prepared by, and are the responsibility of, management and are subject to completion of TPB's customary quarter-end closing and review procedures and third-party review. As a result, TPB's reported information in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 may differ from this information, and any such differences may be material. In addition, the information furnished above does not include all of the information regarding TPB's financial condition and results of operations for the quarter ending September 30, 2025 that may be important to readers. As a result, readers are cautioned not to place undue reliance on the information furnished in this press release and should view this information in the context of TPB's full third quarter 2025 results when such results are disclosed by TPB in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.

    Financial Statements Follow on Subsequent Pages

    Turning Point Brands, Inc.
    Consolidated Statements of Income
    (dollars in thousands except share data)
    (unaudited)
     
    Three Months Ended September 30,

     

    2025

     

     

    2024

     

     
    Net sales

    $

    118,979

     

    $

    90,704

     

    Cost of sales

     

    48,552

     

     

    40,309

     

    Gross profit

     

    70,427

     

     

    50,395

     

    Selling, general, and administrative expenses

     

    44,542

     

     

    29,590

     

    Operating income

     

    25,885

     

     

    20,805

     

    Other (income) expense, net

     

    (4,941

    )

     

    -

     

    Interest expense, net

     

    3,531

     

     

    3,831

     

    Investment (gain) loss

     

    (817

    )

     

    (143

    )

    (Income) losses from equity method investment

     

    (2,117

    )

     

    (60

    )

    Income from continuing operations before income taxes

     

    30,229

     

     

    17,177

     

    Income tax expense

     

    6,472

     

     

    4,652

     

    Income from continuing operations

     

    23,757

     

     

    12,525

     

    Loss from discontinued operations, net of tax

     

    -

     

     

    (165

    )

    Consolidated net income

     

    23,757

     

     

    12,360

     

    Net income (loss) attributable to non-controlling interest

     

    2,677

     

     

    (16

    )

    Net income attributable to Turning Point Brands, Inc.

    $

    21,080

     

    $

    12,376

     

     
    Basic income per common share:
    Continuing operations

    $

    1.16

     

    $

    0.70

     

    Discontinued operations

     

    -

     

     

    -

     

    Net income attributable to Turning Point Brands, Inc.

    $

    1.16

     

    $

    0.70

     

    Diluted income per common share:
    Continuing operations

    $

    1.13

     

    $

    0.68

     

    Discontinued operations

     

    -

     

     

    -

     

    Net income attributable to Turning Point Brands, Inc.

    $

    1.13

     

    $

    0.68

     

    Weighted average common shares outstanding:
    Basic

     

    18,246,722

     

     

    17,722,855

     

    Diluted

     

    18,708,665

     

     

    18,448,720

     

    Turning Point Brands, Inc.
    Consolidated Balance Sheets
    (dollars in thousands except share data)
     
    (unaudited)
    September 30, December 31,
    ASSETS

     

    2025

     

     

    2024

     

    Current assets:
    Cash

    $

    201,189

     

    $

    46,158

     

    Accounts receivable, net of allowances of $174 in 2025 and $66 in 2024

     

    27,792

     

     

    9,624

     

    Inventories, net

     

    112,790

     

     

    96,253

     

    Current assets held for sale

     

    -

     

     

    11,470

     

    Other current assets

     

    54,665

     

     

    34,700

     

    Total current assets

     

    396,436

     

     

    198,205

     

    Property, plant, and equipment, net

     

    33,880

     

     

    26,337

     

    Deferred tax assets, net

     

    -

     

     

    995

     

    Right of use assets

     

    12,915

     

     

    11,610

     

    Deferred financing costs, net

     

    1,341

     

     

    1,823

     

    Goodwill

     

    136,068

     

     

    135,932

     

    Other intangible assets, net

     

    64,344

     

     

    65,254

     

    Master Settlement Agreement (MSA) escrow deposits

     

    29,762

     

     

    28,676

     

    Noncurrent assets held for sale

     

    -

     

     

    3,859

     

    Other assets

     

    68,102

     

     

    20,662

     

    Total assets

    $

    742,848

     

    $

    493,353

     

     
    LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
    Accounts payable

    $

    24,599

     

    $

    11,675

     

    Accrued liabilities

     

    46,738

     

     

    31,096

     

    Current liabilities held for sale

     

    -

     

     

    2,049

     

    Total current liabilities

     

    71,337

     

     

    44,820

     

    Deferred tax liabilities, net

     

    3,971

     

     

    -

     

    Notes payable and long-term debt

     

    293,364

     

     

    248,604

     

    Other long-term liabilities

     

    6,182

     

     

    -

     

    Lease liabilities

     

    9,841

     

     

    9,549

     

    Total liabilities

    $

    384,695

     

    $

    302,973

     

     
    Commitments and contingencies
     
    Stockholders' equity:
    Preferred stock, $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-

     

    -

     

     

    -

     

    Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 20,527,900 issued shares
    and 19,070,757 outstanding shares at September 30, 2025, and 20,200,886 issued shares and
    17,729,481 outstanding shares at December 31, 2024

     

    216

     

     

    202

     

    Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000;
    issued and outstanding shares -0-

     

    -

     

     

    -

     

    Additional paid-in capital

     

    200,376

     

     

    126,662

     

    Cost of repurchased common stock
    (1,457,143 shares at September 30, 2025 and 2,471,405 shares at December 31, 2024)

     

    (47,637

    )

     

    (83,144

    )

    Accumulated other comprehensive loss

     

    (1,900

    )

     

    (2,903

    )

    Accumulated earnings

     

    192,895

     

     

    147,164

     

    Non-controlling interest

     

    14,203

     

     

    2,399

     

    Total stockholders' equity

     

    358,153

     

     

    190,380

     

    Total liabilities and stockholders' equity

    $

    742,848

     

    $

    493,353

     

    Turning Point Brands, Inc.
    Consolidated Statements of Cash Flows
    (dollars in thousands)
    (unaudited)
     

    Nine Months Ended September 30,

     

    2025

     

     

    2024

     

    Cash flows from operating activities:
    Consolidated net income

    $

    56,508

     

    $

    37,459

     

    Loss from discontinued operations, net of tax

     

    -

     

     

    208

     

    Adjustments to reconcile net income to net cash provided by operating activities:
    Loss on extinguishment of debt

     

    1,235

     

     

    -

     

    Loss on sale of property, plant, and equipment

     

    47

     

     

    38

     

    Loss (gain) on investments

     

    (484

    )

     

    2,722

     

    (Income) losses from equity method investment

     

    (2,328

    )

     

    (217

    )

    Depreciation and other amortization expense

     

    4,489

     

     

    3,182

     

    Amortization of other intangible assets

     

    918

     

     

    913

     

    Amortization of deferred financing costs

     

    1,293

     

     

    1,947

     

    Deferred income tax expense

     

    4,690

     

     

    349

     

    Stock compensation expense

     

    5,176

     

     

    5,720

     

    Noncash lease income

     

    (1,205

    )

     

    (317

    )

    Loss on MSA investments

     

    -

     

     

    (14

    )

    Changes in operating assets and liabilities:
    Accounts receivable

     

    (18,251

    )

     

    (447

    )

    Inventories

     

    (16,412

    )

     

    (8,149

    )

    Other current assets

     

    (19,409

    )

     

    1,422

     

    Other assets

     

    (10,978

    )

     

    (814

    )

    Accounts payable

     

    12,709

     

     

    4,565

     

    Accrued liabilities and other

     

    14,517

     

     

    (3,659

    )

    Operating cash flows from continuing operations

     

    32,515

     

     

    44,908

     

    Operating cash flows from discontinued operations

     

    -

     

     

    4,413

     

    Net cash provided by operating activities

    $

    32,515

     

    $

    49,321

     

     
    Cash flows from investing activities:
    Capital expenditures

    $

    (10,182

    )

    $

    (3,516

    )

    Proceeds on the sale of property, plant and equipment

     

    -

     

     

    3

     

    Payment for equity investments

     

    (2,783

    )

     

    -

     

    Purchases of investments

     

    (12,876

    )

     

    (8,865

    )

    Proceeds from sale of investments

     

    5,459

     

     

    4,520

     

    Purchases of non-marketable equity investments

     

    -

     

     

    (1,250

    )

    MSA escrow deposits, net

     

    (2

    )

     

    44

     

    Purchase of option agreement

     

    (8,000

    )

     

    -

     

    Investing cash flows from continuing operations

     

    (28,384

    )

     

    (9,064

    )

    Investing cash flows from discontinued operations

     

    -

     

     

    -

     

    Net cash used in investing activities

    $

    (28,384

    )

    $

    (9,064

    )

     
    Cash flows from financing activities:
    Redemption of 2026 Notes

    $

    (250,000

    )

    $

    -

     

    Proceeds from 2032 Notes

     

    300,000

     

     

    -

     

    At the market offering proceeds

     

    97,499

     

     

    -

     

    Payment of Convertible Senior Notes

     

    -

     

     

    (118,541

    )

    Interchange subscription agreement proceeds

     

    11,000

     

     

    -

     

    Payment of dividends

     

    (4,089

    )

     

    (3,644

    )

    Payment of financing costs

     

    (7,285

    )

     

    (133

    )

    Exercise of options

     

    6,106

     

     

    1,341

     

    Redemption of options

     

    (33

    )

     

    (328

    )

    Issuance of restricted stock units

     

    2

     

     

    -

     

    Redemption of restricted stock units

     

    (2,324

    )

     

    (840

    )

    Issuance of performance based restricted stock units

     

    (1

    )

     

    -

     

    Redemption of performance based restricted stock units

     

    (2,625

    )

     

    (1,212

    )

    Common stock repurchased

     

    -

     

     

    (4,170

    )

    Financing cash flows from continuing operations

     

    148,250

     

     

    (127,527

    )

    Financing cash flows from discontinued operations

     

    -

     

     

    -

     

    Net cash provided by (used in) financing activities

    $

    148,250

     

    $

    (127,527

    )

     
    Net increase in cash

    $

    152,381

     

    $

    (87,270

    )

    Effect of foreign currency translation on cash

    $

    (182

    )

    $

    (29

    )

     
    Cash, beginning of period:
    Unrestricted

    $

    48,941

     

    $

    117,886

     

    Restricted

     

    1,961

     

     

    4,929

     

    Total cash at beginning of period

    $

    50,902

     

    $

    122,815

     

     
    Cash, end of period:
    Unrestricted

    $

    201,189

     

    $

    33,557

     

    Restricted

     

    1,912

     

     

    1,959

     

    Total cash at end of period

    $

    203,101

     

    $

    35,516

     

    Non-GAAP Financial Measures

    To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

    We define "EBITDA" as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization. We define "Adjusted EBITDA" as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Net Income" as net income excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Diluted EPS" as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Operating Income" as operating income excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance.

    Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted Net Income, Adjusted EBITDA, Adjusted Diluted EPS, and Adjusted Operating Income exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.

    In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures.

    Schedule A
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income to Adjusted EBITDA
    (dollars in thousands)
    (unaudited)

    Three Months Ended

    September 30,

    2025

    2024

    Net income attributable to Turning Point Brands, Inc.

    $

    21,080

     

    $

    12,376

    Add:
    Interest expense, net

     

    3,653

     

     

    3,831

    Income tax expense

     

    6,694

     

     

    4,652

    Depreciation expense

     

    814

     

     

    943

    Amortization expense

     

    1,132

     

     

    729

    EBITDA

    $

    33,373

     

    $

    22,531

    Components of Adjusted EBITDA
    Corporate restructuring (a)

     

    233

     

     

    186

    ERP/CRM (b)

     

    -

     

     

    154

    Stock based compensation (c)

     

    1,884

     

     

    1,769

    Transactional expenses and strategic initiatives (d)

     

    820

     

     

    873

    Non-recurring legal (e)

     

    437

     

     

    -

    FDA PMTA (f)

     

    482

     

     

    1,242

    Mark-to-market gain on Canadian inter-company note (g)

     

    (10

    )

     

    -

    Gain on investment (h)

     

    (678

    )

     

    -

    ERC refund (i)

     

    (5,451

    )

     

    -

    Honorarium (j)

     

    255

     

     

    -

    Adjusted EBITDA

    $

    31,345

     

    $

    26,755

    (a) Represents costs associated with corporate restructuring, including severance and early retirement.
    (b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
    (c) Represents non-cash stock options, restricted stock, PRSUs, etc.
    (d) Represents the fees incurred for transaction expenses.
    (e) Represents legal expenses incurred in connection with litigation related to an insurance claim.
    (f) Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA"). The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a onetime resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the remaining two are complete.
    (g) Represents a mark-to-market gain attributable to foreign exchange fluctuation.
    (h) Represents gain on investments.
    (i) Represents an employee retention credit refund received included in other (income) expense, net.
    (j) Represents an honorarium gift included in other (income) expense, net.
    Schedule B
     
    Turning Point Brands
    Reconciliation of GAAP Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS
    (dollars in thousands except share data)
    (unaudited) Three Months Ended Three Months Ended
    September 30, 2025 September 30, 2024
    Income from continuing operations before income taxes Income tax expense (l) Net income attributable to non-controlling interest Net Income Diluted EPS Income from continuing operations before income taxes Income tax expense (l) Loss from discontinued operations, net of tax (m) Net income attributable to non-controlling interest Net Income Diluted EPS
    GAAP Net Income and Diluted EPS

    $

    30,229

     

    $

    6,472

     

    $

    2,677

    $

    21,080

     

    $

    1.13

     

    $

    17,177

    $

    4,652

     

    $

    165

     

    $

    (16

    )

    $

    12,376

    $

    0.68

    Loss on discontinued operations (a)

     

    -

     

     

    -

     

     

    -

     

    -

     

     

    -

     

     

    -

     

    -

     

     

    (165

    )

     

    -

     

     

    165

     

    0.01

    Corporate restructuring (b)

     

    233

     

     

    50

     

     

    -

     

    183

     

     

    0.01

     

     

    186

     

    50

     

     

    -

     

     

    -

     

     

    136

     

    0.01

    ERP/CRM (c)

     

    -

     

     

    -

     

     

    -

     

    -

     

     

    -

     

     

    154

     

    42

     

     

    -

     

     

    -

     

     

    112

     

    0.01

    Stock based compensation (d)

     

    1,884

     

     

    403

     

     

    -

     

    1,481

     

     

    0.08

     

     

    1,769

     

    479

     

     

    -

     

     

    -

     

     

    1,290

     

    0.07

    Transactional expenses and strategic initiatives (e)

     

    820

     

     

    176

     

     

    -

     

    644

     

     

    0.03

     

     

    873

     

    236

     

     

    -

     

     

    -

     

     

    637

     

    0.03

    Non-recurring legal (f)

     

    437

     

     

    94

     

     

    -

     

    343

     

     

    0.02

     

     

    -

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    -

    FDA PMTA (g)

     

    482

     

     

    103

     

     

    -

     

    379

     

     

    0.02

     

     

    1,242

     

    336

     

     

    -

     

     

    -

     

     

    906

     

    0.05

    Mark-to-market gain on Canadian inter-company note (h)

     

    (10

    )

     

    (2

    )

     

    -

     

    (8

    )

     

    (0.00

    )

     

    -

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    -

    Gain on investment (i)

     

    (678

    )

     

    (145

    )

     

    -

     

    (533

    )

     

    (0.03

    )

     

    -

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    -

    ERC refund (j)

     

    (5,451

    )

     

    (1,167

    )

     

    -

     

    (4,284

    )

     

    (0.23

    )

     

    -

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    -

    Honorarium (k)

     

    255

     

     

    55

     

     

    -

     

    200

     

     

    0.01

     

     

    -

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    -

    Tax benefit (l)

     

    -

     

     

    (113

    )

     

    -

     

    113

     

     

    0.01

     

     

    -

     

    (952

    )

     

    -

     

     

    -

     

     

    952

     

    0.05

    Adjusted Net Income and Adjusted Diluted EPS

    $

    28,201

     

    $

    5,925

     

    $

    2,677

    $

    19,599

     

    $

    1.05

     

    $

    21,401

    $

    4,844

     

    $

    -

     

    $

    (16

    )

    $

    16,573

    $

    0.91

    Totals may not foot due to rounding
     
    (a) Represents loss on discontinued operations.
    (b) Represents costs associated with corporate restructuring, including severance and early retirement.
    (c) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
    (d) Represents non-cash stock options, restricted stock, PRSUs, etc.
    (e) Represents the fees incurred for transaction expenses.
    (f) Represents legal expenses incurred in connection with litigation related to an insurance claim.
    (g) Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA"). The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a onetime resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the remaining two are complete.
    (h) Represents a mark-to-market gain attributable to foreign exchange fluctuation.
    (i) Represents gain on option investment.
    (j) Represents an employee retention credit refund received included in other (income) expense, net.
    (k) Represents an honorarium gift included in other (income) expense, net.
    (l) Income tax expense calculated using the effective tax rate for the quarter of 21.4% in 2025 and 27.1% in 2024.
    (m) Tax allocation for discontinued operations excluded from adjusted net income.
    Schedule C
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Operating Income to Adjusted Operating Income
    (dollars in thousands)
    (unaudited)
    Consolidated Zig-Zag Products Stoker's Products
    3rd Quarter 3rd Quarter 3rd Quarter 3rd Quarter 3rd Quarter 3rd Quarter

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     
    Net sales

    $

    118,979

     

    $

    90,704

    $

    44,154

    $

    49,324

    $

    74,825

    $

    41,380

     
    Gross profit

    $

    70,427

     

    $

    50,395

    $

    25,386

    $

    27,324

    $

    45,041

    $

    23,071

     
    Operating income

    $

    25,885

     

    $

    20,805

    $

    15,581

    $

    17,378

    $

    29,270

    $

    17,162

    Adjustments:
    Corporate restructuring

     

    233

     

     

    186

     

    -

     

    -

     

    -

     

    -

    ERP/CRM

     

    -

     

     

    154

     

    -

     

    -

     

    -

     

    -

    Transactional expenses and strategic initiatives

     

    820

     

     

    873

     

    -

     

    -

     

    -

     

    -

    Non-recurring legal

     

    437

     

     

    -

    FDA PMTA

     

    482

     

     

    1,242

     

    -

     

    -

     

    -

     

    -

    Mark-to-market gain on Canadian inter-company note

     

    (10

    )

     

    -

     

    -

     

    -

     

    -

     

    -

    Adjusted operating income

    $

    27,847

     

    $

    23,260

    $

    15,581

    $

    17,378

    $

    29,270

    $

    17,162

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251105115849/en/

    Investor Contacts

    Turning Point Brands, Inc.

    [email protected]

    Get the next $TPB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TPB

    DatePrice TargetRatingAnalyst
    8/1/2025Hold
    Needham
    3/3/2025$80.00Buy
    Alliance Global Partners
    11/14/2024$65.00Outperform
    Oppenheimer
    9/19/2024$50.00Buy
    ROTH MKM
    6/6/2023$28.00Buy
    The Benchmark Company
    10/10/2022$28.00 → $22.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $TPB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares (4,000 units at $31.80), increasing direct ownership by 13% to 34,896 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/18/24 5:01:10 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Chief Revenue Officer Frein Summer bought $69,970 worth of shares (2,260 units at $30.96), increasing direct ownership by 15% to 17,203 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/14/24 6:50:56 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    De Plano Lorenzo bought $420,753 worth of shares (15,043 units at $27.97), increasing direct ownership by 92% to 31,375 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    3/18/24 9:17:02 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Turning Point Brands Announces Third Quarter 2025 Results

    Consolidated Net Sales for Q3 2025 increased 31.2% year-over-year to $119.0 million Modern Oral Net Sales for Q3 2025 increased 627.6% year-over-year to $36.7 million, accounting for 30.8% of total Company Net Sales Q3 2025 Adjusted EBITDA of $31.3 million, up 17.2% over prior year Company increasing 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million) Company increasing full-year Modern Oral sales guidance to $125.0 – 130.0 million (from $100.0 – 110.0 million) Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consuma

    11/5/25 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands to Host Q3 Conference Call

    Turning Point Brands, Inc. (NYSE:TPB) announced the date and time for its conference call to review 3rd quarter 2025 results. The conference call will be on Wednesday, November 5, 2025 at 8:30 a.m. Eastern. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free) (646) 307-1963 (International) Event ID: 6640134 Participants should dial in at least 10 minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/investor-rel

    10/22/25 9:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    FRE Shatters Nicotine Pouch Norms with First High-Strength Watermelon, Answering Overlooked Consumer Demand

    SANTA MONICA, CA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Turning Point Brands (NYSE:TPB), a leader in next-generation nicotine products, today announced the launch of FRE Watermelon, the latest addition to its rapidly growing FRE nicotine pouch portfolio. With this release, FRE becomes the first and only white pouch brand to offer pure across a full assortment of strengths, ranging from 3 to 15 milligrams — a strategic move to capture a rapidly growing, yet underserved, segment of the fruit-flavored pouch market. "We saw a huge disconnect in the market," said Alex Foster, Senior Brand Manager at Turning Point Brands. "Adult consumers were craving bold, authentic fruit flavors but were forced to

    10/8/25 6:55:38 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wexler Lawrence sold $1,898,500 worth of shares (25,000 units at $75.94), decreasing direct ownership by 7% to 330,186 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/18/25 5:27:35 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Sr VP Finance & CAO Wigginton Brian converted options into 10,800 shares and sold $817,236 worth of shares (10,800 units at $75.67) (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/18/25 5:23:32 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    President and CEO Purdy Graham sold $3,853,546 worth of shares (51,400 units at $74.97) and converted options into 51,400 shares (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/13/25 6:26:29 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    SEC Filings

    View All

    Amendment: Turning Point Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K/A - Turning Point Brands, Inc. (0001290677) (Filer)

    11/5/25 12:30:16 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Turning Point Brands, Inc. (0001290677) (Filer)

    11/5/25 7:55:57 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Turning Point Brands Inc.

    SCHEDULE 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    10/8/25 9:59:19 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Turning Point Brands

    Needham initiated coverage of Turning Point Brands with a rating of Hold

    8/1/25 8:13:43 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Alliance Global Partners initiated coverage on Turning Point Brands with a new price target

    Alliance Global Partners initiated coverage of Turning Point Brands with a rating of Buy and set a new price target of $80.00

    3/3/25 8:28:08 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Oppenheimer initiated coverage on Turning Point Brands with a new price target

    Oppenheimer initiated coverage of Turning Point Brands with a rating of Outperform and set a new price target of $65.00

    11/14/24 7:57:59 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Financials

    Live finance-specific insights

    View All

    Turning Point Brands Announces Third Quarter 2025 Results

    Consolidated Net Sales for Q3 2025 increased 31.2% year-over-year to $119.0 million Modern Oral Net Sales for Q3 2025 increased 627.6% year-over-year to $36.7 million, accounting for 30.8% of total Company Net Sales Q3 2025 Adjusted EBITDA of $31.3 million, up 17.2% over prior year Company increasing 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million) Company increasing full-year Modern Oral sales guidance to $125.0 – 130.0 million (from $100.0 – 110.0 million) Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consuma

    11/5/25 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands to Host Q3 Conference Call

    Turning Point Brands, Inc. (NYSE:TPB) announced the date and time for its conference call to review 3rd quarter 2025 results. The conference call will be on Wednesday, November 5, 2025 at 8:30 a.m. Eastern. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free) (646) 307-1963 (International) Event ID: 6640134 Participants should dial in at least 10 minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/investor-rel

    10/22/25 9:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Declares Common Stock Dividend

    The Board of Directors of Turning Point Brands, Inc. ("TPB") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.075 per common share. The dividend is payable on October 10, 2025, to shareholders of record on the close of business on September 19, 2025. About Turning Point Brands, Inc. Turning Point Brands (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic Zig-Zag®, Stoker's®, FRE®, and ALP® brands. T

    8/6/25 4:20:00 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Leadership Updates

    Live Leadership Updates

    View All

    Turning Point Brands Appoints Andrew Flynn as Chief Financial Officer

    Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today the appointment Andrew Flynn as the Company's new Chief Financial Officer, effective on or before April 1, 2024. Mr. Flynn is replacing Louie Reformina, who will step down to pursue other opportunities. Prior to joining Turning Point Brands, Mr. Flynn served as the CFO of Connected Cannabis Co. where he was responsible for bringing sustained profitable growth, expanding geographically and recapitalizing the company. In this role Mr. Flynn operationalized and

    3/11/24 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel

    GRANT-VALKARIA, Fla., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company," or "we"), today announced that it has appointed James W. Dobbins as General Counsel effective December 5, 2023. Barry Hopkins, Executive Chairman of Kaival Brands, said, "James Dobbins has extensive experience advising companies on a breadth of legal matters, and importantly, he also has a deep, relevant understanding of industry business operations, including corporate governance, M&A, international sourcing, and compliance matters. Along with an anticipated reduction in legal expenses, we are thrilled to welcome James to guide and assist our execut

    12/7/23 8:30:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    Kaival Brands Appoints New Chief Executive Officer and Chief Financial Officer

    Former Turning Points Brands executive Thomas Metzler brings decades of finance and operational industry experience to Kaival Brands as its new Chief Financial Officer Current President & Chief Operating Officer Eric Mosser promoted to Chief Executive Officer GRANT-VALKARIA, Fla., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company" or "we," "our" or similar terms), a company focused on incubating and commercializing innovative products into mature and dominant brands, with a current focus on the distribution of electronic nicotine delivery systems (ENDS), which are intended for adults 21 and over, today announced the appoi

    8/3/23 8:15:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    $TPB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/14/24 12:37:11 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 4:32:30 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 12:58:51 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Turning Point Brands Inc. on Jun 18 Indicate?

    On June 18, 2024, Turning Point Brands Inc. experienced a significant insider purchase when Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares. This transaction involved the acquisition of 4,000 units at a price of $31.80 per unit, leading to an increase in his direct ownership by 13% to 34,896 units, as reported in the SEC Form 4. This move by an insider to increase their stake in the company is generally viewed as a positive signal by the market. Examining the recent insider activity at Turning Point Brands Inc., we can identify a few notable trades that occurred around the same time. On May 10, 2024, New insider Catsimatidis John A. Jr claimed ownership of 410,000 sh

    6/18/24 10:08:05 PM ET
    $TPB
    Tobacco
    Consumer Discretionary